Trial in progress: Phase 1 dose escalation study of T-1101, a first-in-class oral Hec1/Nek2 inhibitor, in patients with advanced refractory solid tumors

被引:0
作者
Su, Wu-Chou
Bai, Li-Yuan
Hsiao, Hui-Hua
Shiah, Her-Shyong
Yeh, Yu-Min
Chen, Shang-Hung
Wu, Shang-Yin
Wang, Hui-Ching
Tsai, Hui-Jen
Chang, Kwang-Yu
Tsai, Jui-Hung
Lee, Chun-Hui
Lee, Chieh Hua
Chao, Yu-Sheng
Chen, Li-Tzong
机构
关键词
D O I
10.1158/1538-7445.AM2024-CT167
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT167
引用
收藏
页数:2
相关论文
empty
未找到相关数据